Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.18
+1.5%
$1.22
$0.84
$2.03
$44.91M0.99116,978 shs985 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
Meritage Homes Co. stock logo
MTH
Meritage Homes
$170.01
+3.0%
$159.18
$109.23
$179.68
$6.17B1.77402,584 shs156,666 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-2.52%+1.75%-2.52%+6.42%-28.40%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
Meritage Homes Co. stock logo
MTH
Meritage Homes
+6.70%+9.97%-1.00%-0.23%+35.45%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
2.6529 of 5 stars
3.50.00.00.03.23.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
3.1167 of 5 stars
1.15.02.50.02.72.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00494.28% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
2.29
Hold$172.671.56% Upside

Current Analyst Ratings

Latest MTH, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderperform ➝ Underperform$148.00
4/2/2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeNeutral ➝ Underperform$155.00 ➝ $148.00
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
2/26/2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
Zelman & Associates
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform
2/1/2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$170.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.70N/AN/A$2.97 per share0.40
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
$6.14B1.01$23.04 per share7.38$126.53 per share1.34

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A5/1/2024 (Confirmed)
Meritage Homes Co. stock logo
MTH
Meritage Homes
$738.75M$21.447.938.59N/A12.54%17.92%12.80%7/25/2024 (Estimated)

Latest MTH, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.29N/A-C$0.29N/AN/AN/A
4/24/2024Q1 2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
$3.54$5.06+$1.52$5.06$1.28 billion$1.47 billion  
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million
1/31/2024Q4 2023
Meritage Homes Co. stock logo
MTH
Meritage Homes
$5.18$5.38+$0.20$5.38$1.52 billion$1.65 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
$3.001.76%N/A13.99%1 Years

Latest MTH, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/22/2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
Quarterly$0.751.91%3/14/20243/15/20243/29/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
0.22
1.77
1.77

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
98.44%

Insider Ownership

CompanyInsider Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
28.40%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
2.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
Meritage Homes Co. stock logo
MTH
Meritage Homes
1,83836.32 million35.59 millionOptionable

MTH, BOLT, CZX, and FCR Headlines

SourceHeadline
Meritage Homes First Quarter 2024 Earnings: Beats ExpectationsMeritage Homes First Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - April 26 at 9:29 AM
Meritage Homes (MTH) Q1 2024 Earnings Call TranscriptMeritage Homes (MTH) Q1 2024 Earnings Call Transcript
fool.com - April 26 at 9:29 AM
Meritage Homes (NYSE:MTH) Shares Gap Up  After Strong EarningsMeritage Homes (NYSE:MTH) Shares Gap Up After Strong Earnings
americanbankingnews.com - April 26 at 1:32 AM
Meritage Homes (MTH) Q1 Earnings Beat, Orders & Backlog UpMeritage Homes (MTH) Q1 Earnings Beat, Orders & Backlog Up
zacks.com - April 25 at 2:01 PM
Meritage Homes (NYSE:MTH) Shares Gap Up  Following Better-Than-Expected EarningsMeritage Homes (NYSE:MTH) Shares Gap Up Following Better-Than-Expected Earnings
marketbeat.com - April 25 at 10:49 AM
Meritage Homes (NYSE:MTH) Stock Rating Reaffirmed by WedbushMeritage Homes (NYSE:MTH) Stock Rating Reaffirmed by Wedbush
marketbeat.com - April 25 at 9:18 AM
Meritage Homes Corp. Profit Rises In Q1, Beats estimatesMeritage Homes Corp. Profit Rises In Q1, Beats estimates
markets.businessinsider.com - April 24 at 11:55 PM
MTH Stock Earnings: Meritage Homes Beats EPS, Beats Revenue for Q1 2024MTH Stock Earnings: Meritage Homes Beats EPS, Beats Revenue for Q1 2024
msn.com - April 24 at 11:55 PM
Meritage (MTH) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesMeritage (MTH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com - April 24 at 10:01 PM
Meritage Homes Corp (MTH) Reports Strong Q1 2024 Earnings, Surpassing Analyst ExpectationsMeritage Homes Corp (MTH) Reports Strong Q1 2024 Earnings, Surpassing Analyst Expectations
finance.yahoo.com - April 24 at 6:54 PM
Meritage Homes (NYSE:MTH) Updates FY 2024 Earnings GuidanceMeritage Homes (NYSE:MTH) Updates FY 2024 Earnings Guidance
marketbeat.com - April 24 at 6:12 PM
Meritage Homes reports first quarter 2024 resultsMeritage Homes reports first quarter 2024 results
globenewswire.com - April 24 at 4:30 PM
Meritage Homes Corp.Meritage Homes Corp.
money.usnews.com - April 24 at 8:52 AM
Heres what to expect from Meritage Homess earningsHere's what to expect from Meritage Homes's earnings
markets.businessinsider.com - April 24 at 1:54 AM
Meritage Homes Q1 2024 Earnings PreviewMeritage Homes Q1 2024 Earnings Preview
msn.com - April 23 at 8:54 PM
Meritage Homes: An Upgrade Heading Into Earnings On Strong OrdersMeritage Homes: An Upgrade Heading Into Earnings On Strong Orders
seekingalpha.com - April 21 at 10:33 AM
Mackenzie Financial Corp Reduces Stock Position in Meritage Homes Co. (NYSE:MTH)Mackenzie Financial Corp Reduces Stock Position in Meritage Homes Co. (NYSE:MTH)
marketbeat.com - April 20 at 5:57 AM
Meritage Homes (NYSE:MTH) Shares Gap Up to $150.14Meritage Homes (NYSE:MTH) Shares Gap Up to $150.14
americanbankingnews.com - April 20 at 5:54 AM
Meritage Homes Corporation (MTH)Meritage Homes Corporation (MTH)
finance.yahoo.com - April 19 at 10:52 PM
Strs Ohio Raises Position in Meritage Homes Co. (NYSE:MTH)Strs Ohio Raises Position in Meritage Homes Co. (NYSE:MTH)
marketbeat.com - April 19 at 5:38 AM
Meritage Homes (MTH) Reports Next Week: Wall Street Expects Earnings GrowthMeritage Homes (MTH) Reports Next Week: Wall Street Expects Earnings Growth
finance.yahoo.com - April 17 at 12:46 PM
Meritage Homes (MTH) Reports Next Week: Wall Street Expects Earnings GrowthMeritage Homes (MTH) Reports Next Week: Wall Street Expects Earnings Growth
zacks.com - April 17 at 11:07 AM
Allspring Global Investments Holdings LLC Sells 10,503 Shares of Meritage Homes Co. (NYSE:MTH)Allspring Global Investments Holdings LLC Sells 10,503 Shares of Meritage Homes Co. (NYSE:MTH)
marketbeat.com - April 17 at 5:01 AM
Meritage Homes (MTH) Scheduled to Post Quarterly Earnings on WednesdayMeritage Homes (MTH) Scheduled to Post Quarterly Earnings on Wednesday
americanbankingnews.com - April 17 at 1:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
Meritage Homes logo

Meritage Homes

NYSE:MTH
Meritage Homes Corporation, together with its subsidiaries, designs and builds single-family attached and detached homes in the United States. The company operates through two segments, Homebuilding and Financial Services. It acquires and develops land; and constructs, markets, and sells homes for entry-level and first move-up buyers in Arizona, California, Colorado, Utah, Texas, Florida, Georgia, North Carolina, South Carolina, and Tennessee. The company also offers title and escrow, mortgage, insurance, and closing/settlement services to its homebuyers. Meritage Homes Corporation was founded in 1985 and is based in Scottsdale, Arizona.